实用心脑肺血管病杂志
實用心腦肺血管病雜誌
실용심뇌폐혈관병잡지
PRACTICAL JOURNAL OF CARDIAC CEREBRAL PNEUMAL AND VASCULAR DISEASE
2014年
7期
84-85
,共2页
拉贝洛尔%高血压,妊娠性%血压%妊娠并发症
拉貝洛爾%高血壓,妊娠性%血壓%妊娠併髮癥
랍패락이%고혈압,임신성%혈압%임신병발증
Labetalol%Hypertension,pregnancy - induced%Blood pressure%Pregnancy complications
目的：探讨拉贝洛尔对妊娠高血压患者血压及并发症的影响。方法随机选择2012-2013年在本院住院治疗的妊娠高血压患者90例，将患者随机分为对照组和观察组，各45例。对照组患者给予硫酸镁常规治疗，观察组在对照组治疗的基础上应用拉贝洛尔，观察两组患者治疗期间平均收缩压和舒张压、平均24 h 蛋白尿、并发症发生情况及妊娠结局。结果观察组患者治疗期间平均收缩压、平均舒张压和24 h 蛋白尿低于对照组（P <0.05）；观察组患者胎儿窘迫、新生儿窒息和产后出血发生率均低于对照组（P <0.05）。结论拉贝洛尔可有效降低妊娠高血压患者血压，并减少并发症发生率。
目的：探討拉貝洛爾對妊娠高血壓患者血壓及併髮癥的影響。方法隨機選擇2012-2013年在本院住院治療的妊娠高血壓患者90例，將患者隨機分為對照組和觀察組，各45例。對照組患者給予硫痠鎂常規治療，觀察組在對照組治療的基礎上應用拉貝洛爾，觀察兩組患者治療期間平均收縮壓和舒張壓、平均24 h 蛋白尿、併髮癥髮生情況及妊娠結跼。結果觀察組患者治療期間平均收縮壓、平均舒張壓和24 h 蛋白尿低于對照組（P <0.05）；觀察組患者胎兒窘迫、新生兒窒息和產後齣血髮生率均低于對照組（P <0.05）。結論拉貝洛爾可有效降低妊娠高血壓患者血壓，併減少併髮癥髮生率。
목적：탐토랍패락이대임신고혈압환자혈압급병발증적영향。방법수궤선택2012-2013년재본원주원치료적임신고혈압환자90례，장환자수궤분위대조조화관찰조，각45례。대조조환자급여류산미상규치료，관찰조재대조조치료적기출상응용랍패락이，관찰량조환자치료기간평균수축압화서장압、평균24 h 단백뇨、병발증발생정황급임신결국。결과관찰조환자치료기간평균수축압、평균서장압화24 h 단백뇨저우대조조（P <0.05）；관찰조환자태인군박、신생인질식화산후출혈발생솔균저우대조조（P <0.05）。결론랍패락이가유효강저임신고혈압환자혈압，병감소병발증발생솔。
Objective To explore the effect of labetalol on blood pressure and complications in patients with pregnancy- induced hypertension. Methods 90 patients with pregnancy - induced hypertension in our hospital were chosen from 2012 to 2013,and they were randomly divided into control group and observation group,each of 45 cases. The control group was given Magnesium sulfate,and the observation group was given labetalol based on the control group. The average systolic and diastolic blood pressure,24 h proteinuria,complications and pregnancy outcome of two groups were observed. Results The average sys-tolic and diastolic blood pressure,and 24 h proteinuria of the observation group were lower than those of control group( P <0. 05);the fetal distress,neonatal asphyxia and postpartum hemorrhage of the observation group were lower than those of control group(P < 0. 05). Conclusion Labetalol can effectively reduce the blood pressure and complications of patients with pregnan-cy - induced hypertension.
